Relative Bioavailability of BI 10773 and Linagliptin in Healthy Male Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to investigate the relative bioavailability of BI 10773 and of linagliptin after
concomitant multiple oral administration of 50 mg BI 10773 tablets and 5 mg linagliptin in
comparison to 50 mg BI 10773 and 5 mg linagliptin given alone.